CHLOROQUINE/HYDROXYCHLOROQUINE USAGE OF SARS COV-2 AFFECTED PREGNANT WOMEN
I. Rahmoune*, A. Meftah, I. Jebrane, Y. Kadil, H. Filali
The COVID-19 pandemic made pregnant women a high-risk category of infection. Given the protocol that has been established, first-line treatment is based on Chloroquine (Nivaquine) 500mg ×2/D during 10 days or hydroxychloroquine sulphate (Plaquenil) 200 mg ×3/D for 10 days. In association with: Azithromycin 500 mg at D1 then 250 mg from D2 to D7.
[Full Text Article]